Fortress Biotech, Inc. (FBIO) vs iBio, Inc. (IBIO)
Fortress Biotech, Inc. and iBio, Inc. are both Biotechnology companies. Fortress Biotech, Inc. and iBio, Inc. are of similar size ($77.3M and $76.0M). iBio, Inc. has negative trailing earnings, so its P/E is not meaningful; Fortress Biotech, Inc. trades at 0.7×. Fortress Biotech, Inc. grew revenue faster over the last twelve months: 15.5% against −66.6%. Fortress Biotech, Inc. has the higher net margin (151.0% vs 0.00%) and the lower return on invested capital (−41.3% vs 0.00%). Across the 18 metrics below, Fortress Biotech, Inc. leads on 13 and iBio, Inc. on 5.
Valuation
Profitability
| Metric | FBIO | IBIO | Biotechnology median |
|---|---|---|---|
| Gross margin | 65.59% | 100.00% | 65.16% |
| Operating margin | (42.61%) | 0.00% | 0.00% |
| Net margin | 150.98% | 0.00% | 0.00% |
| Free cash flow margin | 183.80% | 0.00% | 0.00% |
| Return on equity | 84.91% | (65.70%) | (57.72%) |
| Return on assets | 43.38% | (54.04%) | (49.22%) |
| Return on invested capital | (41.34%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack